Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1562902A H5N1 Vaccine Non-inferiority Study
NCT00812981Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Primary completion
- Jun 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Adjupanrix in avian influenza (HPAI), sponsored by GSK. Started Nov 2008; status: completed.
02
Drugs
Adjupanrix
03
Conditions
avian influenza (HPAI)
Beyond the preview
Go deeper on NCT00812981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812981.